extremely significantp < 0.0001
3.3 Findings of the secondary outcomes 3.3.1 HRQoL The intragroup comparison of both groups at day 30 from baseline showed extremely significant improvement ( p < 0.0001) in all parameters of the SF-12 score.
3.3 Findings of the secondary outcomes 3.3.1 HRQoL The intragroup comparison of both groups at day 30 from baseline showed extremely significant improvement ( p < 0.0001) in all parameters of the SF-12 score.